Valley National Advisers’s INmune Bio INMB Stock Holding History

Valley National Advisers’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$5K	–	781
2024 Q3	$5K	Hold	1,000	–	–	﹤0.01%	594
2024 Q2	$8K	Hold	1,000	–	–	﹤0.01%	675
2024 Q1	$11K	Hold	1,000	–	–	﹤0.01%	622
2023 Q4	$11K	Hold	1,000	–	–	﹤0.01%	638
2023 Q3	$7K	Hold	1,000	–	–	﹤0.01%	662
2023 Q2	$10K	Hold	1,000	–	–	﹤0.01%	601
2023 Q1	$8K	Hold	1,000	–	–	﹤0.01%	627
2022 Q4	$7K	Hold	1,000	–	–	﹤0.01%	622
2022 Q3	$7K	Hold	1,000	–	–	﹤0.01%	628
2022 Q2	$10K	Hold	1,000	–	–	﹤0.01%	569
2022 Q1	$8K	Hold	1,000	–	–	﹤0.01%	630
2021 Q4	$10K	Hold	1,000	–	–	﹤0.01%	601
2021 Q3	$19K	Hold	1,000	–	–	﹤0.01%	497
2021 Q2	$18K	Buy	+1,000	New	+$13.5K	﹤0.01%	503
2021 Q1	–	Sell	-2,000	Closed	-$34K	–	880
2020 Q4	$34K	Buy	+2,000	New	+$18.8K	0.01%	357

Other funds holding INMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Valley National Advisers's INMB Position: Q4 2024 in Review

Valley National Advisers sold out of INmune Bio (INMB) in Q4 2024, closing a stake of 1,000 shares — an estimated $5K sold.

Valley National Advisers first reported a position in INMB in Q4 2020 and held it in 15 quarters. The position peaked at $34K in Q4 2020. 73 funds tracked by Wall St. Rank hold INMB as of Q4 2024.

Valley National Advisers reported no remaining INmune Bio position as of Q4 2024 after selling out during the quarter.
Valley National Advisers sold 1,000 INmune Bio shares in Q4 2024, an estimated $5K.
Valley National Advisers first reported a position in INmune Bio in Q4 2020 and held it in 15 quarters.
Valley National Advisers's INmune Bio position peaked at $34K in Q4 2020.
73 funds tracked by Wall St. Rank held INmune Bio as of Q4 2024.

Based on Valley National Advisers's 13F filing for Q4 2024, filed 24 Jan 2025.